The effects of thiophosphate substitutions on native siRNA gene silencing.
RNA mediated interference has emerged as a powerful tool in controlling gene expression in mammalian cells. We investigated the gene silencing properties of six thiophosphate substituted siRNAs (all based on a commercial luciferase medium silencer) compared to that of unmodified siRNA. We also examined the cytotoxicity and dose-response using several thiophosphate modified siRNAs with unmodified siRNA. Our results show that two thiophosphate siRNA sequences convert from medium to high silencers with the addition of four randomly placed thiophosphates. Both thiophosphate siRNAs have a statistically significant difference in luciferase gene silencing (5% and 6% activity) relative to the unmodified native medium silencer referred to as siRNA-2 (18% activity) and four other thiophosphate siRNAs that maintain their medium silencing capability. This indicates that specific thiophosphate substitutions may alter native siRNA function. Further, this shows that thiophosphate siRNAs with the same nucleotide sequence but with different sulfur modification positions have different silencing effects. Both the native siRNA and the thio siRNAs showed a concentration dependent relationship, i.e., with concentration increase, the luciferase gene silencing effect also increased. Confirming cytotoxicity experiments showed no significant changes when HeLa cells were treated with 10nM thiophosphate siRNAs over the course of several days. These results suggest that specific placement of thiophosphates could play an important role in the development of siRNAs as therapeutics by engineering in properties such as strength of binding, nuclease sensitivity, and ultimately efficacy.
Li
Zheng-Yin
ZY
Department of Human Biological Chemistry and the Sealy Center for Structural Biology, 301 University Boulevard, University of Texas Medical Branch, Galveston, TX 77555, USA.
Mao
Haibo
H
Kallick
Deborah A
DA
Gorenstein
David G
DG
D005786:Gene Expression Regulation / Q000235:genetics; D020868:Gene Silencing / Q000502:physiology*; D005818:Genetic Engineering / Q000379:methods*; D006367:HeLa Cells; D006801:Humans; D016297:Mutagenesis, Site-Directed / Q000235:genetics*; D010710:Phosphates / Q000737:chemistry*; D034741:RNA, Small Interfering / Q000737:chemistry* / Q000235:genetics*; D013329:Structure-Activity Relationship; D014162:Transfection / Q000379:methods*
D010710:Phosphates; D034741:RNA, Small Interfering; C035638:thiophosphoric acid